1<!DOCTYPE html>
2
3Anonymous
4/bestp
5/bestp/domrep.nsf
6C4DF603A1722505A85258139005EB921
8
9
10
11
12
13
140
15
16
17/bestp/domrep.nsf/products/C4DF603A1722505A85258139005EB921!OpenDocument
18
19OpenDocument
2018.97.14.83
21
22
23www.best-in-class.com
24/bestp/domrep.nsf
25DB




» Products & Services » » Product Launch » Resource Allocation

Document Excerpt: What it Takes to Successfully Launch an Oncology Product in the U.S. Marketplace: Leveraging Line Extensions

DB Image

ID: MD-562


Features:

9 Info Graphics

20 Data Graphics

200+ Metrics


Pages/Slides: 4


Published: Pre-2020


Delivery Format: Online PDF Document


 

License Options:


Download FREE Excerpt

 

919-403-0251

  • STUDY OVERVIEW
  • BENCHMARK CLASS
  • SPECIAL OFFER
To download this excerpt, click "Download Free Excerpt" on the right.


To return to the study abstract to purchase the full study - click here

This excerpt includes research findings and metrics from document #5462 "What it Takes to Successfully Launch an Oncology Product in the U.S. Marketplace: Leveraging Line Extensions."


Industries Profiled:
Pharmaceutical; Biopharmaceutical; Biotech; Health Care; Manufacturing; Consumer Products; Diagnostic; Medical Device


Companies Profiled:
EMD Serono; Tesaro; Amgen; Pfizer; OTSUKA; Nektar Therapeutics; Medivation; Astellas; Novartis; Bayer; Lilly; Regeneron

If you purchase Best Practice Database document(s), you will have 30 days from the date of purchase to apply some or all of the cost of the document(s) toward the cost of a Full Access Individual, Pharma, Group or University Membership. Write us at DatabaseTeam@bestpracticesllc.com or call David Guinn at 919-767-9179 if you have any questions.